Related Experiment Video

Updated: Jul 11, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 15, 2011

[The therapeutic action of recombinant human interleukin-2 (IL-2) in experimental acute radiation sickness]

S A Rogacheva

    Radiatsionnaia Biologiia, Radioecologiia
    |March 1, 1995
    PubMed

    More Related Videos

    Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles09:57

    Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

    Published on: June 28, 2021

    Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD22608:30

    Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226

    Published on: May 10, 2022

    Related Concept Videos

    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.